Abstract
Positive airway pressure therapy is a core skill in sleep medicine and laboratory practice. This area has seen significant changes since the first edition of the Atlas, including the following: (1) availability and increased familiarity with use and limitations of adaptive ventilation and average/intelligent volume assured pressure ventilation [1–3], (2) the recognition of high loop gain apnea (complex sleep apnea) through morphological and computational analysis of polysomnograms [4–9], (3) demonstrated investigative and clinical efficacy of low-concentration carbon dioxide (CO2) and acetazolamide as positive airway pressure adjuncts [10–15], (4) changes in the pressure profile delivered by clinical devices that attempt to maximize comfort and improve synchrony between the patient and the ventilator, (5) formal guidelines for titration of positive airway pressure and noninvasive ventilation from the American Academy of Sleep Medicine (AASM) [16], which, however, have not been updated as of 2023, and (6) formal recommendations for polysomnography in noninvasive ventilation practice from the SomnoNIV group [17–19]. This chapter will aim to provide complementary information using informative snapshots. Slightly edited summaries of the AASM guidelines are provided below as a starting point, supplemented by discussions of adaptive ventilation, volume assured ventilation, use of dead space, supplemental oxygen, pharmacological protocols, and opiate-induced sleep-disordered breathing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Javaheri S, Brown LK, Randerath WJ. Clinical applications of adaptive servoventilation devices: part 2. Chest. 2014;146:858–68.
Javaheri S, Brown LK, Randerath WJ. Positive airway pressure therapy with adaptive servoventilation: part 1: operational algorithms. Chest. 2014;146:514–23.
Randerath W, Schumann K, Treml M, et al. Adaptive servoventilation in clinical practice: beyond SERVE-HF? ERJ Open Res. 2017:3.
Thomas RJ, Terzano MG, Parrino L, Weiss JW. Obstructive sleep-disordered breathing with a dominant cyclic alternating pattern—a recognizable polysomnographic variant with practical clinical implications. Sleep. 2004;27:229–34.
Oppersma E, Ganglberger W, Sun H, Thomas RJ, Westover MB. Algorithm for automatic detection of self-similarity and prediction of residual central respiratory events during continuous positive airway pressure. Sleep. 2021;44:zsaa215.
Thomas RJ, Mietus JE, Peng CK, et al. Differentiating obstructive from central and complex sleep apnea using an automated electrocardiogram-based method. Sleep. 2007;30:1756–69.
Joosten SA, Landry SA, Wong AM, et al. Assessing the physiologic endotypes responsible for REM- and NREM-based OSA. Chest. 2021;159:1998–2007.
Sands SA, Edwards BA, Terrill PI, et al. Phenotyping pharyngeal pathophysiology using polysomnography in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2018;197:1187–97.
Terrill PI, Edwards BA, Nemati S, et al. Quantifying the ventilatory control contribution to sleep apnoea using polysomnography. Eur Respir J. 2015;45:408–18.
Gilmartin G, McGeehan B, Vigneault K, et al. Treatment of positive airway pressure treatment-associated respiratory instability with enhanced expiratory rebreathing space (EERS). J Clin Sleep Med. 2010;6:529–38.
Thomas RJ, Daly RW, Weiss JW. Low-concentration carbon dioxide is an effective adjunct to positive airway pressure in the treatment of refractory mixed central and obstructive sleep-disordered breathing. Sleep. 2005;28:69–77.
Edwards BA, Connolly JG, Campana LM, et al. Acetazolamide attenuates the ventilatory response to arousal in patients with obstructive sleep apnea. Sleep. 2013;36:281–5.
Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med. 2006;173:234–7.
Ni YN, Yang H, Thomas RJ. The role of acetazolamide in sleep apnea at sea level: a systematic review and meta-analysis. J Clin Sleep Med. 2021;17:1295–304.
Schmickl CN, Landry SA, Orr JE, et al. Acetazolamide for OSA and central sleep apnea: a comprehensive systematic review and meta-analysis. Chest. 2020;158:2632–45.
Kushida CA, Chediak A, Berry RB, et al. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med. 2008;4:157–71.
Gonzalez-Bermejo J, Perrin C, Janssens JP, et al. Proposal for a systematic analysis of polygraphy or polysomnography for identifying and scoring abnormal events occurring during non-invasive ventilation. Thorax. 2012;67:546–52.
Janssens JP, Borel JC, Pepin JL, Somno NIVG. Nocturnal monitoring of home non-invasive ventilation: the contribution of simple tools such as pulse oximetry, capnography, built-in ventilator software and autonomic markers of sleep fragmentation. Thorax. 2011;66:438–45.
Rabec C, Rodenstein D, Leger P, et al. Ventilator modes and settings during non-invasive ventilation: effects on respiratory events and implications for their identification. Thorax. 2011;66:170–8.
Alex RM, Sofer T, Azarbarzin A, et al. Within-night repeatability and long-term consistency of sleep apnea endotypes: the multi-ethnic study of atherosclerosis and osteoporotic fractures in men study. Sleep. 2022;45:zsac129.
Finnsson E, Olafsdottir GH, Loftsdottir DL, et al. A scalable method of determining physiological endotypes of sleep apnea from a polysomnographic sleep study. Sleep. 2021;44:zsaa168.
Camacho M, Song SA, Tolisano AM. Oral pressure therapy (winx) for obstructive sleep apnea: a meta-analysis updating the systematic review. Sleep Breath. 2016;20:1011–2.
Cheng CY, Chen CC, Lo MT, Guilleminault C, Lin CM. Evaluation of efficacy and safety of intraoral negative air pressure device in adults with obstructive sleep apnea in Taiwan. Sleep Med. 2021;81:163–8.
Nokes B, Baptista PM, de Apodaca PMR, et al. Transoral awake state neuromuscular electrical stimulation therapy for mild obstructive sleep apnea. Sleep Breath. 2022;27:527–34.
Kram JA, Pelayo R. Variable negative external pressure-an alternative to continuous positive airway pressure for the treatment of obstructive sleep apnea: a pilot study. J Clin Sleep Med. 2022;18:305–14.
Kram JA, Woidtke RV, Klein KB, Rose RM. Evaluation of continuous negative external pressure (cNEP) for the treatment of obstructive sleep apnea: a pilot study. J Clin Sleep Med. 2017;13:1009–12.
Berry RB, Chediak A, Brown LK, et al. Best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (NPPV) in stable chronic alveolar hypoventilation syndromes. J Clin Sleep Med. 2010;6:491–509.
Franklin KA, Eriksson P, Sahlin C, Lundgren R. Reversal of central sleep apnea with oxygen. Chest. 1997;111:163–9.
Gold AR, Bleecker ER, Smith PL. A shift from central and mixed sleep apnea to obstructive sleep apnea resulting from low-flow oxygen. Am Rev Respir Dis. 1985;132:220–3.
Nakao YM, Ueshima K, Yasuno S, Sasayama S. Effects of nocturnal oxygen therapy in patients with chronic heart failure and central sleep apnea: CHF-HOT study. Heart Vessels. 2016;31:165–72.
Sakakibara M, Sakata Y, Usui K, et al. Effectiveness of short-term treatment with nocturnal oxygen therapy for central sleep apnea in patients with congestive heart failure. J Cardiol. 2005;46:53–61.
Yayan J, Rasche K. Treatment options for central sleep apnea: comparison of ventilator, oxygen, and drug therapies. Adv Exp Med Biol. 2016;905:79–86.
Ebben MR, Narizhnaya M, Segal AZ, Barone D, Krieger AC. A randomised controlled trial on the effect of mask choice on residual respiratory events with continuous positive airway pressure treatment. Sleep Med. 2014;15:619–24.
Genta PR, Kaminska M, Edwards BA, et al. The importance of mask selection on continuous positive airway pressure outcomes for obstructive sleep apnea. An official American Thoracic Society workshop report. Ann Am Thorac Soc. 2020;17:1177–85.
Thomas RJ. Cyclic alternating pattern and positive airway pressure titration. Sleep Med. 2002;3:315–22.
Cao M, Javaheri S. Effects of chronic opioid use on sleep and wake. Sleep Med Clin. 2018;13:271–81.
Chowdhuri S, Javaheri S. Sleep disordered breathing caused by chronic opioid use: diverse manifestations and their management. Sleep Med Clin. 2017;12:573–86.
Javaheri S, Cao M. Chronic opioid use and sleep disorders. Sleep Med Clin. 2022;17:433–44.
Javaheri S, Harris N, Howard J, Chung E. Adaptive servoventilation for treatment of opioid-associated central sleep apnea. J Clin Sleep Med. 2014;10:637–43.
Ferri R, Fulda S, Allen RP, et al. World Association of Sleep Medicine (WASM) 2016 standards for recording and scoring leg movements in polysomnograms developed by a joint task force from the International and the European Restless Legs Syndrome Study Groups (IRLSSG and EURLSSG). Sleep Med. 2016;26:86–95.
Chokroverty S, Bhat S, Gupta D. Respiratory-related leg movements vs periodic limb movements in sleep: a scoring conundrum. An editorial. Sleep Med. 2021;81:98–100.
Lee SA, Lee YS, Cho CW, Yang HR, Im K. Different scoring rules for respiratory event-related leg movements: effects on the prevalence of periodic limb movements during sleep and their association with depressive symptoms in patients with obstructive sleep apnea. Sleep Med. 2021;85:204–10.
Ferri R, DelRosso LM, Provini F, Stefani A, Walters AS, Picchietti DL. Scoring of large muscle group movements during sleep: an International Restless Legs Syndrome Study Group position statement. Sleep. 2021;44:zsab092.
Khayat RN, Xie A, Patel AK, Kaminski A, Skatrud JB. Cardiorespiratory effects of added dead space in patients with heart failure and central sleep apnea. Chest. 2003;123:1551–60.
Lovis A, De Riedmatten M, Greiner D, et al. Effect of added dead space on sleep disordered breathing at high altitude. Sleep Med. 2012;13:663–7.
Patrician A, Tymko MM, Caldwell HG, et al. The effect of an expiratory resistance mask with dead space on sleep, acute mountain sickness, cognition, and ventilatory acclimatization in normobaric hypoxia. High Alt Med Biol. 2019;20:61–70.
Xie A, Rankin F, Rutherford R, Bradley TD. Effects of inhaled CO2 and added dead space on idiopathic central sleep apnea. J Appl Physiol (1985). 1997;82:918–26.
Rastogi R, Badr MS, Ahmed A, Chowdhuri S. Amelioration of sleep-disordered breathing with supplemental oxygen in older adults. J Appl Physiol (1985). 2020;129:1441–50.
Shigemitsu M, Nishio K, Kusuyama T, Itoh S, Konno N, Katagiri T. Nocturnal oxygen therapy prevents progress of congestive heart failure with central sleep apnea. Int J Cardiol. 2007;115:354–60.
Friedman M, Hwang MS, Yalamanchali S, Pott T, Sidhu M, Joseph NJ. Provent therapy for obstructive sleep apnea: impact of nasal obstruction. Laryngoscope. 2016;126:254–9.
Riaz M, Certal V, Nigam G, et al. Nasal expiratory positive airway pressure devices (Provent) for OSA: a systematic review and meta-analysis. Sleep Disord. 2015;2015:734798.
Braga CW, Chen Q, Burschtin OE, Rapoport DM, Ayappa I. Changes in lung volume and upper airway using MRI during application of nasal expiratory positive airway pressure in patients with sleep-disordered breathing. J Appl Physiol (1985). 2011;111:1400–9.
Patel AV, Hwang D, Masdeu MJ, Chen GM, Rapoport DM, Ayappa I. Predictors of response to a nasal expiratory resistor device and its potential mechanisms of action for treatment of obstructive sleep apnea. J Clin Sleep Med. 2011;7:13–22.
Sleeper G, Rashidi M, Strohl KP, et al. Comparison of expiratory pressures generated by four different EPAP devices in a laboratory bench setting. Sleep Med. 2022;96:87–92.
Brown LK. Acetazolamide for central sleep apnea: teaching an old drug new tricks? J Clin Sleep Med. 2021;17:1153–5.
Kwok CT, Wong KC, Kwok CL, Lee SH, Yee KS. Treatment-emergent central sleep apnoea managed by CPAP with adjunctive acetazolamide: a case report. Respirol Case Rep. 2022;10:e0916.
Ni YN, Thomas RJ. Acetazolamide for residual apnea and periodic breathing on continuous positive airway pressure therapy. Sleep Med. 2020;71:52–3.
Eskandari D, Zou D, Karimi M, Stenlof K, Grote L, Hedner J. Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study. Eur Respir J. 2014;44:140–9.
Gaisl T, Haile SR, Thiel S, Osswald M, Kohler M. Efficacy of pharmacotherapy for OSA in adults: a systematic review and network meta-analysis. Sleep Med Rev. 2019;46:74–86.
Westwood AJ, Vendrame M, Montouris G, Auerbach SH. Pearls & oysters: treatment of central sleep apnea with topiramate. Neurology. 2012;78:e97–9.
Hedner J, Stenlof K, Zou D, et al. A randomized controlled clinical trial exploring safety and tolerability of Sulthiame in sleep apnea. Am J Respir Crit Care Med. 2022;205:1461–9.
Giannoni A, Borrelli C, Mirizzi G, Richerson GB, Emdin M, Passino C. Benefit of buspirone on chemoreflex and central apnoeas in heart failure: a randomized controlled crossover trial. Eur J Heart Fail. 2021;23:312–20.
Sankri-Tarbichi AG, Grullon K, Badr MS. Effects of clonidine on breathing during sleep and susceptibility to central apnoea. Respir Physiol Neurobiol. 2013;185:356–61.
Chowdhuri S, Ghabsha A, Sinha P, Kadri M, Narula S, Badr MS. Treatment of central sleep apnea in U.S. veterans. J Clin Sleep Med. 2012;8:555–63.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
1 Electronic Supplementary Material
Palatal myoclonus (see Fig. 53) (MP4 2162 kb)
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Thomas, R.J. (2023). CPAP, Bilevel, APAP, High and Low Loop Gain Syndromes. In: Thomas, R.J., Bhat, S., Chokroverty, S. (eds) Atlas of Sleep Medicine. Springer, Cham. https://doi.org/10.1007/978-3-031-34625-5_32
Download citation
DOI: https://doi.org/10.1007/978-3-031-34625-5_32
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-34624-8
Online ISBN: 978-3-031-34625-5
eBook Packages: MedicineMedicine (R0)